Stifel analyst David Grossman reiterated a Buy rating on DocGo (NASDAQ: DCGO).The analyst commented, "DocGo board again approves extension of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE